Prohibition Partners unlocks the potential of cannabis through data, intelligence and networking. They provide strategic solutions to an international client base of investors, operators, blue-chip companies, FMCG brands and government bodies.

With the legal cannabis industry set to be the next true growth market, and estimated to be worth £2.31 billion by 2024, businesses and investors are in a prime position to capitalise on this first-mover advantage.

Since MGC Pharma’s listing on the London Stock Exchange earlier this month, there has been huge appetite for cannabis-related businesses (“CRBs”) from both institutional and retail investors. With CBD being legalised in 2015 and, even more recently, medical cannabis since November 2019, the legal cannabis industry in the UK is still relatively new and for many, investing in CRBs can feel like an uncertain area.

Prohibition Partners, the leading market intelligence firm for the global cannabis industry, is hosting a roundtable webinar for its ‘London is Open’ series, exploring the opportunities for medicinal cannabis and CBD companies listing on the London stock markets this year.

https://www.share-talk.com/stephen-murphy-co-founder-ceo-of-prohibition-partners-interview/